RESUMO
An ability of poorly differentiated cells of different genesis, including tumor stem-like cells (TSCs), to internalize extracellular double-stranded DNA (dsDNA) fragments was revealed in our studies. Using the models of Krebs-2 murine ascites carcinoma and EBV-induced human B-cell lymphoma culture, we demonstrated that dsDNA internalization into the cell consists of several mechanistically distinct phases. The primary contact with cell membrane factors is determined by electrostatic interactions. Firm contacts with cell envelope proteins are then formed, followed by internalization into the cell of the complex formed between the factor and the dsDNA probe bound to it. The key binding sites were found to be the heparin-binding domains, which are constituents of various cell surface proteins of TSCs-either the C1q domain, the collagen-binding domain, or domains of positively charged amino acids. These results imply that the interaction between extracellular dsDNA fragments and the cell, as well as their internalization, took place with the involvement of glycocalyx components (proteoglycans/glycoproteins (PGs/GPs) and glycosylphosphatidylinositol-anchored proteins (GPI-APs)) and the system of scavenger receptors (SRs), which are characteristic of TSCs and form functional clusters of cell surface proteins in TSCs. The key provisions of the concept characterizing the principle of organization of the "group-specific" cell surface factors of TSCs of various geneses were formulated. These factors belong to three protein clusters: GPs/PGs, GIP-APs, and SRs. For TSCs of different tumors, these clusters were found to be represented by different members with homotypic functions corresponding to the general function of the cluster to which they belong.
Assuntos
Carcinoma Krebs 2 , Células-Tronco Neoplásicas , Humanos , Animais , Camundongos , Células-Tronco Neoplásicas/metabolismo , DNA/metabolismo , Glicoproteínas/metabolismo , Membrana Celular/metabolismo , Carcinoma Krebs 2/patologia , Proteínas de Membrana/metabolismoRESUMO
Topotecan is a cytostatic drug from the camptothecin group, it acts by inhibiting topoisomerase 1 (TOP1). Tyrosyl-DNA phosphodiesterase 1 (TDP1) is capable of interfering with the action of TOP1 inhibitors, reducing their therapeutic efficacy. Suppression of TDP1 activity may enhance the effects of topotecan. In this work, we investigated the effect of the antitumor drug topotecan alone and in combination with a TDP1 inhibitor, a hydrazinothiazole derivative of usnic acid, on Krebs-2 mouse ascites tumors. We have previously shown that this derivative efficiently inhibits TDP1. In the present work, we show that both topotecan and the TDP1 inhibitor have an antitumor effect when evaluated separately. The combination of topotecan and the TDP1 inhibitor additively reduces both the weight of the ascites tumor and the number of cells in ascites. In mice, the TDP1 inhibitor alone or in combination with topotecan eliminated the tumor cells. After the combined intraperitoneal administration of these two compounds, we observed cells in which lipid droplets occupied almost the entire cytoplasm and the accumulation of cell detritus, which was absent in the samples collected from mice treated with each compound separately.
Assuntos
Carcinoma Krebs 2 , Topotecan , Animais , Ascite , DNA , Camundongos , Diester Fosfórico Hidrolases/genética , Topotecan/farmacologiaRESUMO
Tyrosyl-DNA phosphodiesterase 1 (Tdp1) is an important DNA repair enzyme in humans, and a current and promising inhibition target for the development of new chemosensitizing agents due to its ability to remove DNA damage caused by topoisomerase 1 (Top1) poisons such as topotecan and irinotecan. Herein, we report our work on the synthesis and characterization of new Tdp1 inhibitors that combine the arylcoumarin (neoflavonoid) and monoterpenoid moieties. Our results showed that they are potent Tdp1 inhibitors with IC50 values in the submicromolar range. In vivo experiments with mice revealed that compound 3ba (IC50 0.62 µM) induced a significant increase in the antitumor effect of topotecan on the Krebs-2 ascites tumor model. Our results further strengthen the argument that Tdp1 is a druggable target with the potential to be developed into a clinically-potent adjunct therapy in conjunction with Top1 poisons.
Assuntos
Carcinoma Krebs 2/tratamento farmacológico , Carcinoma Pulmonar de Lewis/tratamento farmacológico , Monoterpenos , Proteínas de Neoplasias , Inibidores de Fosfodiesterase , Diester Fosfórico Hidrolases/metabolismo , Animais , Carcinoma Krebs 2/enzimologia , Carcinoma Krebs 2/patologia , Carcinoma Pulmonar de Lewis/enzimologia , Carcinoma Pulmonar de Lewis/patologia , Feminino , Humanos , Células MCF-7 , Masculino , Camundongos , Monoterpenos/síntese química , Monoterpenos/química , Monoterpenos/farmacologia , Proteínas de Neoplasias/antagonistas & inibidores , Proteínas de Neoplasias/metabolismo , Inibidores de Fosfodiesterase/síntese química , Inibidores de Fosfodiesterase/química , Inibidores de Fosfodiesterase/farmacologia , Relação Estrutura-AtividadeRESUMO
Electron-microscopic analysis of the ultrastructure of the Krebs-2 carcinoma ascites cells in the first 90 min immediately after their exposure to fragmented double-stranded DNA has been performed. Morphological attributes of the treated cancer cells indicate the induction in these cells of destructive processes of presumably apoptotic type. The predominance of dystrophic-destructive changes in cells after the addition of DNA is supposed to be a consequence of the disturbance in metabolic processes caused by the experimental action.
Assuntos
Carcinoma Krebs 2/ultraestrutura , Membrana Celular/ultraestrutura , Citoplasma/ultraestrutura , DNA/ultraestrutura , Animais , Apoptose/fisiologia , Ascite , DNA/metabolismo , Camundongos , Microscopia Eletrônica/métodosRESUMO
Due to wide spreading of inflammatory disease and imperfection of available anti-inflammatory drugs, mainly associated with their serious side effects, searching for new anti-inflammatory agents is a pressing problem. Natural triterpenoids and their synthetic analogs are a promising source of new drugs. In this study, we have investigated the anti-inflammatory and antitumor effects in vivo of the glycyrrhetinic acid derivative soloxolone methyl (SM), or methyl 2-cyano-3,12-dioxo-18ßH-olean-9(ll),l(2)-dien-30-oate. SM was shown to efficiently suppress the development of edema in a mouse model of carrageenan- or histamine-induced acute inflammation. SM also inhibited the tumor growth and reduced the tumor cell count in the ascitic fluid in mice bearing Krebs-2 carcinoma, the development of which is accompanied by an inflammatory process in the surrounding tissues.
Assuntos
Carcinoma Krebs 2/tratamento farmacológico , Ácido Glicirretínico , Animais , Carcinoma Krebs 2/metabolismo , Carcinoma Krebs 2/patologia , Ensaios de Seleção de Medicamentos Antitumorais , Ácido Glicirretínico/análogos & derivados , Ácido Glicirretínico/química , Ácido Glicirretínico/farmacologia , Inflamação/tratamento farmacológico , Inflamação/metabolismo , Inflamação/patologia , Masculino , Camundongos , Camundongos Endogâmicos ICRRESUMO
Using the ability of poorly differentiated cells to natively internalize fragments of extracellular double-stranded DNA as a marker, we isolated a tumorigenic subpopulation present in Krebs-2 ascites that demonstrated the features of tumor-inducing cancer stem cells. Having combined TAMRA-labeled DNA probe and the power of RNA-seq technology, we identified a set of 168 genes specifically expressed in TAMRA-positive cells (tumor-initiating stem cells), these genes remaining silent in TAMRA-negative cancer cells. TAMRA+ cells displayed gene expression signatures characteristic of both stem cells and cancer cells. The observed expression differences between TAMRA+ and TAMRA- cells were validated by Real Time PCR. The results obtained corroborated the biological data that TAMRA+ murine Krebs-2 tumor cells are tumor-initiating stem cells. The approach developed can be applied to profile any poorly differentiated cell types that are capable of immanent internalization of double-stranded DNA.
Assuntos
Biomarcadores Tumorais/genética , Carcinoma Krebs 2/genética , Diferenciação Celular , Perfilação da Expressão Gênica/métodos , Transcriptoma , Elementos Alu , Animais , Biomarcadores Tumorais/metabolismo , Carcinoma Krebs 2/patologia , DNA/genética , DNA/metabolismo , Corantes Fluorescentes/metabolismo , Regulação Neoplásica da Expressão Gênica , Redes Reguladoras de Genes , Sequenciamento de Nucleotídeos em Larga Escala , Células-Tronco Neoplásicas/metabolismo , Células-Tronco Neoplásicas/patologia , Fenótipo , Reação em Cadeia da Polimerase em Tempo Real , Rodaminas/metabolismo , Análise de Sequência de RNA , Transdução de SinaisRESUMO
We describe the strategy, which allows curing experimental mice engrafted with Krebs-2 ascites. The strategy is based on the facts that i) Krebs-2 tumor-initiating stem cells (TISCs) are naturally capable of internalizing fragments of extracellular double-stranded DNA (dsDNA); ii) upon delivery into TISCs, these dsDNA fragments interfere with the on-going DNA repair process so that TISCs either die or lose their tumorigenic potential. The following 3-step regimen of therapeutic procedures leading to eradication of Krebs-2 ascites is considered. Firstly, three timed injections of cyclophosphamide (CP) exactly matching the interstrand cross-link (ICL) repair phases that lead to synchronization of ascites cells in late S/G2/M. Secondly, additional treatment of ascites 18 hours post each CP injection (at NER/HR transition timepoint) with a composite dsDNA-based preparation interfering with the NER and HR repair pathways, so that tumorigenic properties of ascites cells are compromised. Thirdly, final treatment of mice with a combination of CP and dsDNA injections as ascites cells undergo apoptotic destruction, and the surviving TAMRA+ TISCs arrested in late S/G2/M phases massively enter into G1/S, when they regain sensitivity to CP+dsDNA treatment. Thus, this regimen assures that no viable cells, particularly Krebs-2 TISCs, remain.
Assuntos
Ascite/tratamento farmacológico , Carcinoma Krebs 2/tratamento farmacológico , Ciclofosfamida/administração & dosagem , Células-Tronco Neoplásicas/efeitos dos fármacos , Animais , Ascite/genética , Ascite/metabolismo , Ascite/patologia , Carcinoma Krebs 2/genética , Carcinoma Krebs 2/metabolismo , Carcinoma Krebs 2/patologia , DNA/administração & dosagem , DNA/genética , Modelos Animais de Doenças , Esquema de Medicação , Feminino , Humanos , Masculino , Camundongos , Camundongos Endogâmicos C57BL , Células-Tronco Neoplásicas/patologia , TransfecçãoRESUMO
It has been established previously that up to 40% of mouse CD34(+) hematopoietic stem cells are capable of internalizing exogenous dsDNA fragments both in vivo and ex vivo. Importantly, when mice are treated with a combination of cyclophosphamide and dsDNA, the repair of interstrand crosslinks in hematopoietic progenitors is attenuated, and their pluripotency is altered. Here we show for the first time that among various actively proliferating mammalian cell populations there are subpopulations capable of internalizing dsDNA fragments. In the context of cancer, such dsDNA-internalizing cell subpopulations display cancer stem cell-like phenotype. Furthermore, using Krebs-2 ascites cells as a model, we found that upon combined treatment with cyclophosphamide and dsDNA, engrafted material loses its tumor-initiating properties which we attribute to the elimination of tumor-initiating stem cell subpopulation or loss of its tumorigenic potential.
Assuntos
Apoptose/efeitos dos fármacos , Células-Tronco Neoplásicas/patologia , Animais , Antineoplásicos/farmacologia , Ascite/metabolismo , Ascite/patologia , Neoplasias Encefálicas/metabolismo , Neoplasias Encefálicas/patologia , Carcinoma Krebs 2/metabolismo , Carcinoma Krebs 2/patologia , Proliferação de Células/efeitos dos fármacos , Ciclofosfamida/farmacologia , DNA/metabolismo , DNA/farmacologia , Endocitose , Glioblastoma/metabolismo , Glioblastoma/patologia , Xenoenxertos , Camundongos Endogâmicos CBA , Camundongos Endogâmicos NOD , Camundongos SCID , Células-Tronco Neoplásicas/efeitos dos fármacos , Reparo de DNA por Recombinação/genética , Células Tumorais CultivadasRESUMO
Herein, we report a novel strategy to engineer an acid-sensitive anticancer theranostic agent using a vector-drug ensemble. The ensemble was synthesized by directly conjugating the linoleic acid (LA)-modified branched polyethyleneimine with a chemotherapeutic drug trifluorothymidine. Linoleic acid residues were grafted onto 25 kDa polyethyleneimine (PEI) by treating PEI with linoleic acid chloroanhydride. 5-Trifluoromethyl-2'-deoxyuridine (trifluorothymidine, TFT) was introduced into LA-PEI conjugate by phosphorylating the conjugate with amidophosphate of trifluorothymidine 5'-monophosphate (pTFT), which had been activated by its conversion into the N,N-dimethylaminopyridine derivative. The extent of mononucleotide analog incorporation in the polymer was regulated by the ratio of pTFT to the polymer during the synthesis. Samples containing 20-70 TFT residues per PEI molecule were obtained. The cytotoxicity of PEI-LA-pTFT conjugates decreased with increasing nucleotide content, as examined using the MTT method. Due to the presence of fluorine atoms, TFT-based conjugates could be detected directly in the animals by (19)F magnetic resonance imaging. In addition, the presence of the amidophosphate group in PEI-LA-pTFT conjugates allowed their detection by in vivo(31)P NMR spectroscopy. Indeed, the (31)P NMR signal of a phosphoramide (δ ~ 12 ppm) was observed in the mouse muscle tissue treated with PEI-LA-pTFT conjugate along with the signals from endogenous phosphorus-containing compounds. At the same time, the use of PEI-LA-pTFT conjugate for chemotherapeutic drug delivery is limited due to the low release of pTFT from the carrier. To enhance the release of the drug from the conjugate in the endosomes, PEI-LA polymer was coupled with urocanic acid (UA), which bears imidazole ring and thus can form an acid-labile P-N bond with pTFT. The PEI-LA-UA-pTFT conjugate containing 30 residues of UA and 40 residues of pTFT was tested against the murine Krebs-II ascites carcinoma, grown as an ascetic tumor. The intraperitoneal injection of the conjugates resulted in prolongation of the animals' life and to the complete disappearance of the tumor after three injections.
Assuntos
Antineoplásicos/química , Antineoplásicos/uso terapêutico , Ácido Linoleico/química , Polietilenoimina/análogos & derivados , Trifluridina/química , Trifluridina/uso terapêutico , Animais , Antineoplásicos/administração & dosagem , Antineoplásicos/farmacocinética , Carcinoma Krebs 2/tratamento farmacológico , Linhagem Celular Tumoral , Portadores de Fármacos/química , Humanos , Ligantes , Camundongos , Camundongos Endogâmicos C57BL , Trifluridina/administração & dosagem , Trifluridina/farmacocinéticaRESUMO
In this issue of Molecular Cell, Fabian et al. (2009) demonstrate that in cell-free extracts from mouse Krebs-2 ascites, microRNA-mediated translational repression precedes target mRNA deadenylation, and identify GW182, PABP, and deadenylase subunits CAF1 and CCR4 as factors required for deadenylation.
Assuntos
Inativação Gênica , MicroRNAs/metabolismo , Proteínas de Ligação a Poli(A)/metabolismo , Proteínas/metabolismo , Processamento Pós-Transcricional do RNA , RNA Mensageiro/metabolismo , Complexo de Inativação Induzido por RNA/metabolismo , Animais , Proteínas Argonautas , Ascite/genética , Ascite/metabolismo , Autoantígenos/metabolismo , Sítios de Ligação , Carcinoma Krebs 2/genética , Carcinoma Krebs 2/metabolismo , Fator de Iniciação 2 em Eucariotos/metabolismo , Fator de Iniciação Eucariótico 4G/metabolismo , Exorribonucleases , Humanos , Cinética , Camundongos , Proteínas de Ligação a Poli(A)/genética , Biossíntese de Proteínas , Estrutura Terciária de Proteína , Proteínas/genética , Estabilidade de RNA , Complexo de Inativação Induzido por RNA/genética , Receptores CCR4/metabolismo , Proteínas Repressoras , RibonucleasesRESUMO
MicroRNAs (miRNAs) inhibit mRNA expression in general by base pairing to the 3'UTR of target mRNAs and consequently inhibiting translation and/or initiating poly(A) tail deadenylation and mRNA destabilization. Here we examine the mechanism and kinetics of miRNA-mediated deadenylation in mouse Krebs-2 ascites extract. We demonstrate that miRNA-mediated mRNA deadenylation occurs subsequent to initial translational inhibition, indicating a two-step mechanism of miRNA action, which serves to consolidate repression. We show that a let-7 miRNA-loaded RNA-induced silencing complex (miRISC) interacts with the poly(A)-binding protein (PABP) and the CAF1 and CCR4 deadenylases. In addition, we demonstrate that miRNA-mediated deadenylation is dependent upon CAF1 activity and PABP, which serves as a bona fide miRNA coactivator. Importantly, we present evidence that GW182, a core component of the miRISC, directly interacts with PABP via its C-terminal region and that this interaction is required for miRNA-mediated deadenylation.
Assuntos
Inativação Gênica , MicroRNAs/metabolismo , Proteínas de Ligação a Poli(A)/metabolismo , Proteínas/metabolismo , Processamento Pós-Transcricional do RNA , RNA Mensageiro/metabolismo , Complexo de Inativação Induzido por RNA/metabolismo , Animais , Proteínas Argonautas , Ascite/genética , Ascite/metabolismo , Autoantígenos/metabolismo , Sítios de Ligação , Carcinoma Krebs 2/genética , Carcinoma Krebs 2/metabolismo , Sistema Livre de Células , Fator de Iniciação 2 em Eucariotos/metabolismo , Fator de Iniciação Eucariótico 4G/metabolismo , Exorribonucleases , Células HeLa , Humanos , Cinética , Camundongos , Proteínas de Ligação a Poli(A)/genética , Biossíntese de Proteínas , Estrutura Terciária de Proteína , Proteínas/genética , Estabilidade de RNA , Complexo de Inativação Induzido por RNA/genética , Receptores CCR4/metabolismo , Proteínas Repressoras , Ribonucleases , TransfecçãoRESUMO
According to generally accepted scanning model proposed by M. Kozak, the secondary structure of 5'-untranslated regions (5'-UTR) of eukaryotic mRNAs can only cause an inhibitory effect on the translation initiation since it would counteract migration of the 40S ribosomal subunit along the mRNA polynucleotide chain. Thus, the existence of efficiently translatable mRNAs with long and highly structured 5'-UTRs is not compatible with the cap-dependent scanning mechanism. It is expected that such mRNAs should use alternative ways of translation initiation to be efficiently translated, first of all the mechanism of the internal ribosome entry mediated by special RNA structures called IRESes (for Internal Ribosome Entry Sites), which have been proposed to reside within their 5'-UTRs. In this paper, it is shown that this point of view is not correct and most probably based on experiments of mRNA translation in rabbit reticulocyte lysate. This cell free system does not reflect correctly the ratio of translation efficiencies of various mRNAs which is observed in the living cell. Using five different mRNAs of similar design which possess either relatively short leaders of cellular mRNAs (beta-globin and beta-actin mRNAs) or long and highly structured 5'-UTRs (c-myc, LINE-1, Apaf-1 mRNAs), we show that the translation activities of all tested 5'-UTRs are comparable, both in transfected cells and in a whole cytoplasmic extract of cultivated cells. This activity is strongly dependent on the presence of the cap at their 5'-ends.
Assuntos
Regiões 5' não Traduzidas/fisiologia , Conformação de Ácido Nucleico , Iniciação Traducional da Cadeia Peptídica/fisiologia , Capuzes de RNA/metabolismo , Subunidades Ribossômicas Menores/metabolismo , Animais , Carcinoma Krebs 2 , Sistema Livre de Células , Camundongos , CoelhosRESUMO
A Krebs-2 cell-free extract that efficiently translates encephalomyocarditis virus (EMCV) RNA and extensively processes the viral polyprotein is also capable of supporting complete infectious EMCV replication. The system displays high RNA synthesis activity and de novo synthesis of virus up to titers of 2 x 10(7) to 6 x 10(7) plaque-forming units (pfu)/ml. The preparation of Krebs-2 cell extract and methods of analysis of EMCV-specific processes in vitro are described. We also demonstrate that the Krebs-2 cell-free system translates the entire open reading frame of the hepatitis C virus (HCV) RNA and properly processes the viral polyprotein when supplemented with canine microsomal membranes. In addition to processing, other posttranslational modifications of HCV proteins take place in vitro, such as the N-terminal glycosylation of the E1 and the E2 precursor (E2-p7) and phosphorylation of NS5A. The HCV RNA-programmed Krebs-2 cell-free extract should prove very useful as a novel screen for drugs that inhibit NS3-mediated processing. The use of this system should help fill the gap in understanding the regulation of synthesis and maturation of HCV proteins. With further optimization of cell-free conditions, the entire reconstitution of infectious HCV synthesis in vitro might become feasible.
Assuntos
Vírus da Encefalomiocardite/metabolismo , Genoma Viral/fisiologia , Hepacivirus/metabolismo , Biossíntese de Proteínas/fisiologia , RNA Viral/fisiologia , Replicação Viral/fisiologia , Animais , Carcinoma Krebs 2/metabolismo , Sistema Livre de Células , Feminino , Glicosilação , Camundongos , Proteínas do Envelope Viral/metabolismoRESUMO
MicroRNAs (miRNAs) play an important role in gene regulatory networks in animals. Yet, the mechanistic details of their function in translation inhibition or messenger RNA (mRNA) destabilization remain controversial. To directly examine the earliest events in this process, we have developed an in vitro translation system using mouse Krebs-2 ascites cell-free extract that exhibits an authentic miRNA response. We show here that translation initiation, specifically the 5' cap recognition process, is repressed by endogenous let-7 miRNAs within the first 15 minutes of mRNA exposure to the extract when no destabilization of the transcript is observed. Our results indicate that inhibition of translation initiation is the earliest molecular event effected by miRNAs. Other mechanisms, such as mRNA degradation, may subsequently consolidate mRNA silencing.
Assuntos
Fator de Iniciação 4F em Eucariotos/fisiologia , Regulação da Expressão Gênica/fisiologia , MicroRNAs/fisiologia , Biossíntese de Proteínas/fisiologia , Capuzes de RNA/fisiologia , Animais , Carcinoma Krebs 2 , Extratos Celulares , Vírus da Encefalomiocardite/genética , Luciferases de Renilla/genética , Camundongos , Ribossomos/metabolismoRESUMO
Pools of 26S and 20S proteasomes were studied in the spleen, liver, lung, and ascitic carcinoma Krebs-II of mouse. Western blotting demonstrated that the pool of 26S proteasomes in ascitic carcinoma Krebs-II was twice that in control lung cells and did not significantly differ by total 26S proteasome quantities from the spleen and liver. At the same time, the level of immune subunit LMP7 was 12 times lower in it compared to lung proteasomes and 4-5 times lower compared to spleen and liver proteasomes. Immune subunit LMP2 was undetectable by this technique in the ascitic carcinoma in contrast to the lung, spleen, and liver. All immune subunits in the studied organs and ascitic carcinoma Krebs-II are components of 26S but not 20S proteasomes.
Assuntos
Carcinoma Krebs 2/imunologia , Cisteína Endopeptidases/imunologia , Complexo de Endopeptidases do Proteassoma/imunologia , Animais , Western Blotting , Camundongos , Especificidade de Órgãos/imunologiaRESUMO
We developed a system for complete replication of encephalomyocarditis virus (EMCV) in a test tube by using an in vitro translation extract from Krebs-2 cells. Efficient virus synthesis occurred in a narrow range of Mg(2+) and EMCV RNA concentrations. Excess input RNA impaired RNA replication and virus production but not translation. This suggests the existence of a negative-feedback mechanism for regulation of RNA replication by the viral plus-strand RNA or proteins.
Assuntos
Sistema Livre de Células , Vírus da Encefalomiocardite/metabolismo , Biossíntese de Proteínas , RNA Viral/biossíntese , Replicação Viral , Animais , Carcinoma Krebs 2/metabolismo , Carcinoma Krebs 2/virologia , Vírus da Encefalomiocardite/genética , Proteínas Virais/metabolismo , Virologia/métodosRESUMO
The growth of a transplantable murine non-Hodgkin lymphoma tumour, developing either intraperitoneally as an ascites tumour or subcutaneously as a solid tumour, has been shown to be markedly diminished by including phytohaemagglutinin (PHA), a lectin present in raw kidney bean (Phaseolus vulgaris) in the diet. In NMRI mice fed PHA within the range 0.45-7.0 mg/g diet, tumours which developed during a 10 day period after subcutaneous injection of cells were about 35% of the dry weight of those in lactalbumin-fed (control) animals. The reduced rate of growth occurred in a dose-dependent manner within the range 0.45-3.5 mg/g diet. Based on these observations it has been suggested that a competition between the gut epithelium undergoing hyperplasia and the developing tumour may occur for nutrients from a common body pool, and this may be an important factor with regard to the observed initial low level of tumour growth following the feeding of a PHA-containing diet. Observations which showed that the level of hyperplasia of the small bowel in response to feeding the PHA diets was higher in non-injected mice compared to those which had been injected with tumour cells substantiated the concept of competition between gut and tumour for nutrients etc. required for growth. Experiments with a second murine tumour cell line (a plasmacytoma) in Balb/c mice gave similar results indicating that the effect of PHA was not restricted to a single tumour system.
Assuntos
Carcinoma Krebs 2/prevenção & controle , Dieta , Hiperplasia/induzido quimicamente , Intestinos/patologia , Linfoma não Hodgkin/prevenção & controle , Fito-Hemaglutininas/farmacologia , Animais , Humanos , Lactalbumina/administração & dosagem , Camundongos , Fito-Hemaglutininas/administração & dosagem , Poliaminas/metabolismoRESUMO
Infection of cells with picornaviruses, such as poliovirus and encephalomyocarditis virus (EMCV), causes a shutoff of host protein synthesis. The molecular mechanism of the shutoff has been partly elucidated for poliovirus but not for EMCV. Translation initiation in eukaryotes is facilitated by the mRNA 5' cap structure to which the multisubunit translation initiation factor eIF4F binds to promote ribosome binding. Picornaviruses use a mechanism for the translation of their RNA that is independent of the cap structure. Poliovirus infection engenders the cleavage of the eIF4G (formerly p220) component of eIF4F and renders this complex inactive for cap-dependent translation. In contrast, EMCV infection does not result in eIF4G cleavage. Here, we report that both EMCV and poliovirus activate a translational repressor, 4E-BP1, that inhibits cap-dependent translation by binding to the cap-binding subunit eIF4E. Binding of eIF4E occurs only to the underphosphorylated form of 4E-BP1, and this interaction is highly regulated in cells. We show that 4E-BP1 becomes dephosphorylated upon infection with both EMCV and poliovirus. Dephosphorylation of 4E-BP1 temporally coincides with the shutoff of protein synthesis by EMCV but lags behind the shutoff and eIF4G cleavage in poliovirus-infected cells. Dephosphorylation of 4E-BP1 by specifically inhibiting cap-dependent translation may be the major cause of the shutoff phenomenon in EMCV-infected cells.
Assuntos
Carcinoma Krebs 2/metabolismo , Proteínas de Transporte , Vírus da Encefalomiocardite/fisiologia , Regulação Viral da Expressão Gênica , Fatores de Iniciação de Peptídeos/metabolismo , Fosfoproteínas/metabolismo , Poliovirus/fisiologia , Biossíntese de Proteínas , Proteínas Repressoras/metabolismo , Proteínas Adaptadoras de Transdução de Sinal , Animais , Western Blotting , Proteínas de Ciclo Celular , Fator de Iniciação 4F em Eucariotos , Fatores de Iniciação em Eucariotos , Células HeLa , Humanos , Camundongos , Camundongos Endogâmicos BALB C , Fosfoproteínas/isolamento & purificação , Fosforilação , Capuzes de RNA/metabolismo , Células Tumorais CultivadasRESUMO
Almost twice as many ascites tumour cells were recovered from mice pre-fed for 3 days on a lactalbumin (La)-based control diet, injected with Krebs II ascites cells and then maintained on the same diet for a further 8 days, when compared with mice fed on a phytohaemagglutinin-containing (PHA) diet for the whole period. A dietary switch on the day of injection of tumour cells produced an intermediate effect; mice switched to the La diet after pre-feeding on PHA for 3 days developed somewhat more tumour cells than when the opposite dietary switch was performed. The polyamine content in the tumour cells was lowest in the mice fed on La, and highest in mice fed PHA for the duration of the experiment, respectively. Since large amounts of extraneous polyamines are required in order to sustain tumour growth, and the hyperplastic growth of the gut which occurs in response to injesting the lectin is a polyamine-dependent process, it is evident that the two growth signals compete with one another for important nutrients/growth factors, including polyamines.